Difficult-to-Treat Pathogens: A Review on the Management of Multidrug-Resistant Staphylococcus epidermidis

Abstract

Multidrug-resistant Staphylococcus epidermidis (MDRSE) is responsible for difficult-to-treat infections in humans and hospital-acquired-infections. This review discusses the epidemiology, microbiology, diagnosis, and treatment of MDRSE infection and identifies knowledge gaps. By using the search term “pan resistant Staphylococcus epidermidis” OR “multi-drug resistant Staphylococcus epidermidis” OR “multidrug-resistant lineages of Staphylococcus epidermidis”, a total of 64 records have been identified from various previously published studies. The proportion of methicillin resistance in S. epidermidis has been reported to be as high as 92%. Several studies across the world have aimed to detect the main phylogenetic lineages and antibiotically resistant genes through culture, mass spectrometry, and genomic analysis. Molecular biology tools are now available for the identification of S. epidermidis and its drug resistance mechanisms, especially in blood cultures. However, understanding the distinction between a simple colonization and a bloodstream infection (BSI) caused by S. epidermidis is still a challenge for clinicians. Some important parameters to keep in mind are the number of positive samples, the symptoms and signs of the patient, the comorbidities of the patient, the presence of central venous catheter (CVC) or other medical device, and the resistance phenotype of the organism. The agent of choice for empiric parenteral therapy is vancomycin. Other treatment options, depending on different clinical settings, may include teicoplanin, daptomycin, oxazolidinones, long-acting lipoglycopeptides, and ceftaroline. For patients with S. epidermidis infections associated with the presence of an indwelling device, assessment regarding whether the device warrants removal is an important component of management. This study provides an overview of the MDRSE infection. Further studies are needed to explore and establish the most correct form of management of this infection.

Evaluation of visible light and natural photosensitizers against Staphylococcus epidermidis and Staphylococcus saprophyticus planktonic cells and biofilm

“…Hospital-acquired infections (HAI) are considered a major issue globally, with various types of bacteria exerting the highest impact on the occurrence of these infections. Different Staphylococcus spp., which form a part of human natural skin microbiota, have been very often isolated from diverse clinical sources and form a clinically significant group of bacteria causing nosocomial infections [ [ [1] , [2] , [3] , [4] ]]. Among all the staphylococci (staph) group, Staphylococcus aureus is the most renowned pathogen, contributing to dangerous human and animal infections, including bloodstream infections and foodborne intoxications (FI).…”

Borrelia burgdorferi and autoimmune mechanisms: implications for mimicry, misdiagnosis, and mismanagement in Lyme disease and autoimmune disorders

“…In addition, Borrelia can alter their surface proteins, facilitating immune evasion [3]. The ability to persist in diverse host tissues, including joints, skin, and the central nervous system, underlines their adaptability and pathogenic potential [4].…”

Molecular Characterization of Clinical Linezolid-Resistant Staphylococcus epidermidis in a Tertiary Care Hospital

“…S. epidermidis has the ability to form a biofilm that impedes phagocytosis by immune cells and the effect of antimicrobial peptides, hence weakening the efficiency of antibiotic therapy [ 4 ]. In addition, device-associated infections cause enormous medical and economic burdens on healthcare systems worldwide [ 5 ].…”